Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms

&NA; Epidemiological studies have implied that diabetes mellitus (DM) will become an epidemic accompany with metabolic and endocrine disorders worldwide. Most of DM patients are affected by type 2 diabetes mellitus (T2DM) with insulin resistance and insulin secretion defect. Generally, the strategies to treat T2DM are diet control, moderate exercise, hypoglycemic and lipid‐lowing agents. Despite the therapeutic benefits for the treatment of T2DM, most of the drugs can produce some undesirable side effects. Considering the pathogenesis of T2DM, natural products (NPs) have become the important resources of bioactive agents for anti‐T2DM drug discovery. Recently, more and more natural components have been elucidated to possess anti‐T2DM properties, and many efforts have been carried out to elucidate the possible mechanisms. The aim of this paper was to overview the activities and underlying mechanisms of NPs against T2DM. Developments of anti‐T2DM agents will be greatly promoted with the increasing comprehensions of NPs for their multiple regulating effects on various targets and signal pathways. Graphical abstract Figure. No caption available.

[1]  Zhaoqian Liu,et al.  Huperzine A Ameliorates Cognitive Deficits in Streptozotocin-Induced Diabetic Rats , 2014, International journal of molecular sciences.

[2]  S. Vyas,et al.  Evaluation of the effect of piperine per se on blood glucose level in alloxan-induced diabetic mice. , 2012, Acta poloniae pharmaceutica.

[3]  Jen-kun Lin,et al.  Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. , 2009, Journal of agricultural and food chemistry.

[4]  G. Derosa,et al.  Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. , 2013, Current topics in medicinal chemistry.

[5]  J. Baur Biochemical effects of SIRT1 activators. , 2010, Biochimica et biophysica acta.

[6]  M. Lorenzo,et al.  Insulin resistance associated to obesity: the link TNF-alpha. , 2008, Archives of physiology and biochemistry.

[7]  A. Mahmoud,et al.  Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. , 2012, Journal of diabetes and its complications.

[8]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[9]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[10]  P. S. M. Prince,et al.  Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes , 2006, Journal of biochemical and molecular toxicology.

[11]  I. Zupkó,et al.  Chlorogenic Acid and Rutin Play a Major Role in the In Vivo Anti-Diabetic Activity of Morus alba Leaf Extract on Type II Diabetic Rats , 2012, PloS one.

[12]  Jinzi Wu,et al.  Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications , 2016, Biochemistry insights.

[13]  Do Yeon Kim,et al.  Beneficial effect of betulinic acid on hyperglycemia via suppression of hepatic glucose production. , 2014, Journal of agricultural and food chemistry.

[14]  T. Takeuchi,et al.  Evodiamine Inhibits Insulin-Stimulated mTOR-S6K Activation and IRS1 Serine Phosphorylation in Adipocytes and Improves Glucose Tolerance in Obese/Diabetic Mice , 2013, PloS one.

[15]  J. Bhatt,et al.  Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. , 2012, Nutrition research.

[16]  F. Russo,et al.  Hydroxytyrosol Inhibits Cannabinoid CB1 Receptor Gene Expression in 3T3‐L1 Preadipocyte Cell Line , 2016, Journal of cellular physiology.

[17]  Xiubo Jiang,et al.  Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies , 2014, European Journal of Nutrition.

[18]  W. Ni,et al.  Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms. , 2015, European journal of pharmacology.

[19]  B. Sümegi,et al.  Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. , 2011, The British journal of nutrition.

[20]  J. Staessen,et al.  Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People , 2016, PloS one.

[21]  Do Yeon Kim,et al.  Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice. , 2014, Fitoterapia.

[22]  R. Curi,et al.  Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function , 2012, Lipids in Health and Disease.

[23]  I. Naseem,et al.  Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. , 2014, Life sciences.

[24]  N. Ashokkumar,et al.  Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats. , 2014, Toxicology and applied pharmacology.

[25]  David C Wright,et al.  Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  P. Zancan,et al.  Antidiabetic activity of Sedum dendroideum: Metabolic enzymes as putative targets for the bioactive flavonoid kaempferitrin , 2014, IUBMB life.

[27]  C. Mameli,et al.  An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations , 2017, Pharmacological research.

[28]  K. Okoshi,et al.  Influence of rutin treatment on biochemical alterations in experimental diabetes. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  D. S. Arya,et al.  Preclinical Evidence for the Pharmacological Actions of Naringin: A Review , 2014, Planta Medica.

[30]  J. Gálvez,et al.  Flavonoids in Inflammatory Bowel Disease: A Review , 2016, Nutrients.

[31]  A. Abdel-Moneim,et al.  Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats , 2017, Metabolic Brain Disease.

[32]  N. Balakrishna,et al.  Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[33]  B. Sears,et al.  The role of fatty acids in insulin resistance , 2015, Lipids in Health and Disease.

[34]  A. Nagy,et al.  In Vivo Effects of Quercetin in Association with Moderate Exercise Training in Improving Streptozotocin-Induced Aortic Tissue Injuries , 2015, Molecules.

[35]  M. Fatehi,et al.  A review on natural products for controlling type 2 diabetes with an emphasis on their mechanisms of actions. , 2013, Current diabetes reviews.

[36]  Hui-yu Liu,et al.  Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5′-AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[37]  S. Nabavi,et al.  Curcumin: a natural product for diabetes and its complications. , 2015, Current topics in medicinal chemistry.

[38]  Wei-Jia Kong,et al.  Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. , 2009, Metabolism: clinical and experimental.

[39]  F. Gao,et al.  Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. , 2013, American journal of physiology. Endocrinology and metabolism.

[40]  Yong-Ki Park,et al.  Effects of Icariin on insulin resistance via the activation of AMPK pathway in C2C12 mouse muscle cells. , 2015, European journal of pharmacology.

[41]  Y. Qi,et al.  Herbal medicines and nonalcoholic fatty liver disease. , 2016, World journal of gastroenterology.

[42]  I. Andreadou,et al.  Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet‐induced metabolic syndrome: Pharmacological and metabolism‐based investigation , 2017, Pharmacological research.

[43]  Jie Dong,et al.  Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: Role of NF-kappa B signaling. , 2013, European journal of pharmacology.

[44]  H. Kontani,et al.  Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice. , 2003, Biological & pharmaceutical bulletin.

[45]  L. Dimeglio,et al.  Type 1 Diabetes , 2019, Epidemiology of Diabetes.

[46]  A. Pandey,et al.  Chemistry and Biological Activities of Flavonoids: An Overview , 2013, TheScientificWorldJournal.

[47]  Kun-song Chen,et al.  Hypoglycemic and hypolipidemic effects of neohesperidin derived from Citrus aurantium L. in diabetic KK-A(y) mice. , 2015, Food & function.

[48]  G. Hatch,et al.  Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. , 2015, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[49]  W. Xie,et al.  Diabetes is an inflammatory disease: evidence from traditional Chinese medicines , 2011, Diabetes, obesity & metabolism.

[50]  O. Ahmed,et al.  Navel orange peel hydroethanolic extract, naringin and naringenin have anti-diabetic potentials in type 2 diabetic rats. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[51]  J. Nadler,et al.  Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative–nitrosative stress and p38 MAPK activation , 2011, Experimental Neurology.

[52]  P. S. M. Prince,et al.  Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin‐induced diabetic rats , 2006, The Journal of pharmacy and pharmacology.

[53]  P. O'Brien Molecular mechanisms of quinone cytotoxicity. , 1991, Chemico-biological interactions.

[54]  H. Ashida,et al.  Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. , 2007, Biochemical pharmacology.

[55]  A. El-Mowafy,et al.  Novel role of curcumin combined with bone marrow transplantation in reversing experimental diabetes: Effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines. , 2011, European journal of pharmacology.

[56]  Li Yang,et al.  Andrographolide Prevents High-Fat Diet–Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[57]  T. Ninomiya,et al.  Diabetes Mellitus and Dementia , 2014, Current Diabetes Reports.

[58]  M. Jeschke,et al.  Endoplasmic reticulum stress and insulin resistance post-trauma: similarities to type 2 diabetes , 2012, Journal of cellular and molecular medicine.

[59]  C. Rochitte,et al.  Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial. , 2017, JCI insight.

[60]  Vinita Tiwari,et al.  DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. , 2012, Diabetes research and clinical practice.

[61]  F. Alsaraj Pathogenesis of Type 2 Diabetes Mellitus , 2015 .

[62]  H. Kishida,et al.  Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. , 2005, Journal of agricultural and food chemistry.

[63]  C. Girgis,et al.  Novel links between HIFs, type 2 diabetes, and metabolic syndrome , 2012, Trends in Endocrinology & Metabolism.

[64]  M. Reed,et al.  Isolation and antihyperglycemic activity of bakuchiol from Otholobium pubescens (Fabaceae), a Peruvian medicinal plant used for the treatment of diabetes. , 1999, Biological & pharmaceutical bulletin.

[65]  Mi Young Lee,et al.  Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes , 2011, Experimental & Molecular Medicine.

[66]  L. Philipson,et al.  Update on diabetes classification. , 2015, The Medical clinics of North America.

[67]  T. Netticadan,et al.  Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients , 2013, Evidence-based complementary and alternative medicine : eCAM.

[68]  T. Ishida,et al.  Effect of corosolic acid on dietary hypercholesterolemia and hepatic steatosis in KK-Ay diabetic mice. , 2010, Biomedical research.

[69]  Pengfei Lv,et al.  Emodin up‐regulates glucose metabolism, decreases lipolysis, and attenuates inflammation in vitro大黄素在体内上调糖代谢、减少脂解和抑制炎症反应 , 2015, Journal of diabetes.

[70]  A. Zamoner,et al.  Involvement of GLUT‐4 in the stimulatory effect of rutin on glucose uptake in rat soleus muscle , 2013, The Journal of pharmacy and pharmacology.

[71]  Shiping Ma,et al.  Hypoglycemic and antioxidant activities of paeonol and its beneficial effect on diabetic encephalopathy in streptozotocin-induced diabetic rats. , 2013, Journal of medicinal food.

[72]  Suowen Xu,et al.  Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway , 2011, Molecular and Cellular Endocrinology.

[73]  G. Gajski,et al.  Assessment of DNA damage and lipid peroxidation in diabetic mice: effects of propolis and epigallocatechin gallate (EGCG). , 2013, Mutation research.

[74]  Siqingaowa Suo,et al.  Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. , 2012, Free radical biology & medicine.

[75]  A. Gruslin,et al.  The effects of dietary polyphenols on reproductive health and early development. , 2015, Human reproduction update.

[76]  Xiao-Qin Ding,et al.  Quercetin and allopurinol reduce liver thioredoxin‐interacting protein to alleviate inflammation and lipid accumulation in diabetic rats , 2013, British journal of pharmacology.

[77]  M. White,et al.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 , 2012, Diabetologia.

[78]  Luyong Zhang,et al.  Maslinic acid reduces blood glucose in KK-Ay mice. , 2007, Biological & pharmaceutical bulletin.

[79]  V. Ramachandran,et al.  Glucose uptake through translocation and activation of GLUT4 in PI3K/Akt signaling pathway by asiatic acid in diabetic rats , 2015, Human & experimental toxicology.

[80]  Kenji Suzuki,et al.  Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy , 2011, Nutrition & metabolism.

[81]  Haiyan Xu,et al.  FFA‐Induced Adipocyte Inflammation and Insulin Resistance: Involvement of ER Stress and IKKβ Pathways , 2011, Obesity.

[82]  M. Portillo,et al.  Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet. , 2013, Nutrition.

[83]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[84]  M. Gonthier,et al.  Anti‐inflammatory and antioxidant effects of polyphenols extracted from Antirhea borbonica medicinal plant on adipocytes exposed to Porphyromonas gingivalis and Escherichia coli lipopolysaccharides , 2017, Pharmacological research.

[85]  M. Lee,et al.  Anti-diabetic properties of chrysophanol and its glucoside from rhubarb rhizome. , 2008, Biological & pharmaceutical bulletin.

[86]  Peng-bin Lai,et al.  Quercetin Ameliorates Diabetic Nephropathy by Reducing the Expressions of Transforming Growth Factor-β1 and Connective Tissue Growth Factor in Streptozotocin-Induced Diabetic Rats , 2012, Renal failure.

[87]  Shuren Ma,et al.  Jatrorrhizine hydrochloride attenuates hyperlipidemia in a high-fat diet-induced obesity mouse model. , 2016, Molecular medicine reports.

[88]  Shiping Ma,et al.  Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. , 2016, European journal of pharmacology.

[89]  Mengying Xu,et al.  Effects of D-Pinitol on Insulin Resistance through the PI3K/Akt Signaling Pathway in Type 2 Diabetes Mellitus Rats. , 2015, Journal of agricultural and food chemistry.

[90]  A. Hameed,et al.  Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[91]  K. Miyashita,et al.  Effect of caffeine and capsaicin on the blood glucose levels of obese/diabetic KK-A(y) mice. , 2012, Journal of oleo science.

[92]  Akilavalli Narasimhan,et al.  Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat. , 2015, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[93]  Suling Huang,et al.  Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice , 2012, Acta Pharmacologica Sinica.

[94]  T. Sasaoka,et al.  Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans , 2004, BMC pharmacology.

[95]  Guan-zhong Wu,et al.  Genistein: a promising therapeutic agent for obesity and diabetes treatment. , 2013, European journal of pharmacology.

[96]  Zhimin Chen,et al.  Chlorogenic Acid Improves Late Diabetes through Adiponectin Receptor Signaling Pathways in db/db Mice , 2015, PloS one.

[97]  F. Haj,et al.  Decreased adiposity and enhanced glucose tolerance in shikonin treated mice , 2015, Obesity.

[98]  P. R. Rajamohanan,et al.  Discovering Bisdemethoxycurcumin from Curcuma longa rhizome as a potent small molecule inhibitor of human pancreatic α-amylase, a target for type-2 diabetes. , 2012, Food chemistry.

[99]  Chul-Hoon Lee,et al.  High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment. , 2014, Biological & pharmaceutical bulletin.

[100]  G. Seghieri,et al.  Sex‐gender‐related therapeutic approaches for cardiovascular complications associated with diabetes , 2017, Pharmacological research.

[101]  Zhanhua Liang,et al.  Baicalein alters PI3K/Akt/GSK3β signaling pathway in rats with diabetes-associated cognitive deficits. , 2015, International journal of clinical and experimental medicine.

[102]  W. Deng,et al.  Baicalein, a natural product, selectively activating AMPKα2 and ameliorates metabolic disorder in diet-induced mice , 2012, Molecular and Cellular Endocrinology.

[103]  Jae Heun Lee,et al.  The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis. , 2009, Molecular nutrition & food research.

[104]  É. Hajduch,et al.  Protein kinase C isoforms: Mediators of reactive lipid metabolites in the development of insulin resistance , 2011, FEBS letters.

[105]  Mi-Kyung Lee,et al.  Antihyperglycemic and Antioxidant Properties of Caffeic Acid in db/db Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[106]  D. James,et al.  Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.

[107]  Ning Zhang,et al.  Protective and anti‑angiopathy effects of ginsenoside Re against diabetes mellitus via the activation of p38 MAPK, ERK1/2 and JNK signaling. , 2016, Molecular medicine reports.

[108]  R. Heuberger,et al.  The effect of acute caffeine intake on insulin sensitivity and glycemic control in people with diabetes. , 2017, Diabetes & metabolic syndrome.

[109]  Ramkumar Veppathur Mohan,et al.  MicroRNAs as pharmacological targets in diabetes. , 2013, Pharmacological research.

[110]  A. Marette,et al.  Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance , 2014, Reviews in Endocrine and Metabolic Disorders.

[111]  Xuefeng Yu,et al.  Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction. , 2013, DNA and cell biology.

[112]  B. Viollet,et al.  AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol , 2009, Diabetes.

[113]  Ming-Tsang Wu,et al.  Betel nut extract and arecoline block insulin signaling and lipid storage in 3T3-L1 adipocytes , 2011, Cell Biology and Toxicology.

[114]  Chunhui Song,et al.  Tetrandrine down-regulates expression of miRNA-155 to inhibit signal-induced NF-κB activation in a rat model of diabetes mellitus. , 2015, International journal of clinical and experimental medicine.

[115]  W. Xiao,et al.  Protective Effects of Oxymatrine on Experimental Diabetic Nephropathy , 2014, Planta Medica.

[116]  S. Banerjee,et al.  Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. , 2012, Pharmacological research.

[117]  Xiao-Yi Zeng,et al.  Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target , 2015, British journal of pharmacology.

[118]  Dongwei Zhang,et al.  Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety , 2017, Pharmacological research.

[119]  David C. Thomas,et al.  Autophagy in diabetes: β-cell dysfunction, insulin resistance, and complications. , 2015, DNA and cell biology.

[120]  G. Beccuti,et al.  Timing of food intake: Sounding the alarm about metabolic impairments? A systematic review , 2017, Pharmacological research.

[121]  N. Abate,et al.  Body Fat Distribution and Insulin Resistance , 2013, Nutrients.

[122]  C. Lamendola,et al.  Risk factors for type 2 diabetes mellitus. , 2002, The Journal of cardiovascular nursing.

[123]  R. Taliyan,et al.  Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes. , 2016, Pharmacological research.

[124]  R. Tamler,et al.  Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know , 2010, Postgraduate medicine.

[125]  D. Benaiges,et al.  Type 1 diabetes, metabolic syndrome and cardiovascular risk. , 2014, Metabolism: clinical and experimental.

[126]  Yuefeng Ji,et al.  Experimental demonstration of multi-dimensional resources integration for service provisioning in cloud radio over fiber network , 2016, Scientific Reports.

[127]  Å. Sjöholm,et al.  Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice , 2012, Nutrition & Metabolism.

[128]  C. Frost,et al.  Marrubiin, a constituent of Leonotis leonurus, alleviates diabetic symptoms. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[129]  S. Assaad-Khalil,et al.  Resveratrol Promotes Foot Ulcer Size Reduction in Type 2 Diabetes Patients , 2014, ISRN endocrinology.

[130]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[131]  Kelly E Heim,et al.  Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. , 2002, The Journal of nutritional biochemistry.

[132]  Priyanka Singh,et al.  Potential Dual Role of Eugenol in Inhibiting Advanced Glycation End Products in Diabetes: Proteomic and Mechanistic Insights , 2016, Scientific Reports.

[133]  Li-ping Yang,et al.  Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. , 2009, Investigative ophthalmology & visual science.

[134]  A. Osbourn,et al.  Metabolic and functional diversity of saponins, biosynthetic intermediates and semi-synthetic derivatives , 2014, Critical reviews in biochemistry and molecular biology.

[135]  S. Yoon,et al.  Protective effects of epigallocatechin gallate (EGCG) on streptozotocin-induced diabetic nephropathy in mice. , 2014, Acta histochemica.

[136]  Jianping Ye,et al.  Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. , 2011, American journal of physiology. Endocrinology and metabolism.

[137]  W. Ling,et al.  Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. , 2012, World journal of diabetes.

[138]  H. Labazi,et al.  Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome , 2017, Pharmacological research.

[139]  L. Ferrucci,et al.  Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. , 2013, Cell metabolism.

[140]  Caroline Pereira Domingueti,et al.  Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. , 2016, Journal of diabetes and its complications.

[141]  L. Abenhaim,et al.  Rates of hypoglycemia in users of sulfonylureas. , 1997, Journal of clinical epidemiology.

[142]  T. Szkudelski,et al.  Resveratrol and diabetes: from animal to human studies. , 2015, Biochimica et biophysica acta.

[143]  J-J Gu,et al.  A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats. , 2012, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[144]  Yawei Xu,et al.  Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway , 2014, Diabetes & vascular disease research.

[145]  J. Ha,et al.  Antidiabetes and Antiobesity Effect of Cryptotanshinone via Activation of AMP-Activated Protein Kinase , 2007, Molecular Pharmacology.

[146]  A. Zarzuelo,et al.  Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. , 2009, Biochemical pharmacology.

[147]  C. Ballantyne,et al.  Skeletal muscle inflammation and insulin resistance in obesity , 2017, The Journal of clinical investigation.

[148]  B. Deepa,et al.  Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats , 2013, Toxicology mechanisms and methods.

[149]  P. Salimath,et al.  Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats. , 2012, Clinical nutrition.

[150]  Lulu Chen,et al.  Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial β-oxidation. , 2011, Metabolism: clinical and experimental.

[151]  Thomas A. Burgess,et al.  Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle. , 2011, Archives of surgery.

[152]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[153]  Tonghua Liu,et al.  Tanshinone I alleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[154]  Yong-Bin Wang,et al.  Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes , 2014, Experimental and therapeutic medicine.

[155]  A. Sayed,et al.  Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy in rats. , 2010, European review for medical and pharmacological sciences.

[156]  T. Tsuda,et al.  Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. , 2010, The Journal of nutrition.

[157]  Gao Fy,et al.  A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats. , 2012 .

[158]  S. Yim,et al.  Epigallocatechin gallate stimulates glucose uptake through the phosphatidylinositol 3-kinase-mediated pathway in L6 rat skeletal muscle cells. , 2008, Journal of medicinal food.

[159]  M. Cooper,et al.  Mechanisms of diabetic complications. , 2013, Physiological reviews.

[160]  Ki-Suk Kim,et al.  The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice , 2015, Scientific Reports.

[161]  Wei Xu,et al.  Effect of astragaloside IV on hepatic glucose‐regulating enzymes in diabetic mice induced by a high‐fat diet and streptozotocin , 2010, Phytotherapy research : PTR.

[162]  Dragan M. Svrakic,et al.  Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment , 2015, Drugs.

[163]  G. Lewis,et al.  High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[164]  C. Frost,et al.  Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders , 2014, The Journal of pharmacy and pharmacology.

[165]  Mark I McCarthy,et al.  Genomics, type 2 diabetes, and obesity. , 2010, The New England journal of medicine.

[166]  J. Boucher,et al.  Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. , 2015, Journal of the Academy of Nutrition and Dietetics.

[167]  J. B. Lopes de Faria,et al.  Theobromine increases NAD⁺/Sirt-1 activity and protects the kidney under diabetic conditions. , 2015, American journal of physiology. Renal physiology.

[168]  Soyoung Kim,et al.  Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. , 2011, Biochemical pharmacology.

[169]  Wei Zhang,et al.  Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects , 2013, Molecular and Cellular Endocrinology.

[170]  K. Jeong,et al.  The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. , 2004, The Journal of nutrition.

[171]  S. Nah Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors , 2014, Front. Physiol..

[172]  P. Shanthi,et al.  Effect of tangeretin, a polymethoxylated flavone on glucose metabolism in streptozotocin-induced diabetic rats. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[173]  O. Franco,et al.  The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[174]  Yu Li,et al.  Anti-diabetic effects of luteolin and luteolin-7-O-glucoside on KK-Ay mice , 2016, Bioscience, biotechnology, and biochemistry.

[175]  J. Li,et al.  Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9) , 2016, Cardiovascular Diabetology.

[176]  Jie Wei,et al.  The protection of Rhein lysinate to liver in diabetic mice induced by high-fat diet and streptozotocin , 2015, Archives of pharmacal research.

[177]  Craig I Coleman,et al.  Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. , 2010, JAMA.

[178]  Wen-Chang Chang,et al.  Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats , 2015, Nutrients.

[179]  E. Zocchi,et al.  Microgram amounts of abscisic acid in fruit extracts improve glucose tolerance and reduce insulinemia in rats and in humans , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[180]  J. Li,et al.  Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway. , 2014, European journal of pharmacology.

[181]  Role of ceramide in apoptosis and development of insulin resistance , 2016, Biochemistry (Moscow).

[182]  Claudio Soto,et al.  Type 2 diabetes as a protein misfolding disease. , 2015, Trends in molecular medicine.

[183]  F. Mattace-Raso,et al.  Sex‐ and gender‐related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature , 2017, Pharmacological research.

[184]  M. Jois,et al.  Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. , 2009, Nutrition research.

[185]  Hui Yang,et al.  Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats. , 2015, International immunopharmacology.

[186]  H. Ji,et al.  Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg/Th17 balance. , 2015, International immunopharmacology.

[187]  M. Senese,et al.  Alkaloids from Marine Invertebrates as Important Leads for Anticancer Drugs Discovery and Development , 2014, Molecules.

[188]  Jing Shang,et al.  Asiatic acid mitigates hyperglycemia and reduces islet fibrosis in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model. , 2015, Chinese journal of natural medicines.

[189]  Jin-jian Lu,et al.  Biological activities of salvianolic acid B from Salvia miltiorrhiza on type 2 diabetes induced by high-fat diet and streptozotocin , 2015, Pharmaceutical biology.

[190]  Libin Zhou,et al.  Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFα in 3T3‐L1 adipocytes , 2008, Phytotherapy research : PTR.

[191]  Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats , 2014, Molecular and Cellular Biochemistry.

[192]  J. Gu,et al.  Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis. , 2012, Fitoterapia.

[193]  M. Esmaeili,et al.  Antioxidant and protective effects of major flavonoids from Teucrium polium on beta-cell destruction in a model of streptozotocin-induced diabetes. , 2009, Planta medica.

[194]  Linhua Zhao,et al.  Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies. , 2014, World journal of gastroenterology.

[195]  Jing Shang,et al.  Maslinic acid modulates glycogen metabolism by enhancing the insulin signaling pathway and inhibiting glycogen phosphorylase. , 2014, Chinese journal of natural medicines.

[196]  F. Gao,et al.  Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. , 2009, Journal of agricultural and food chemistry.

[197]  Young Kun Kim,et al.  Effects of Pinitol on Glycemic Control, Insulin Resistance and Adipocytokine Levels in Patients with Type 2 Diabetes Mellitus , 2011, Annals of Nutrition and Metabolism.

[198]  Pei Wang,et al.  Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARγ Signaling , 2015, Diabetes.

[199]  M. Yoshikawa,et al.  Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes , 2005, BMC complementary and alternative medicine.

[200]  A. Ghorbani Mechanisms of antidiabetic effects of flavonoid rutin. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[201]  Kui-Jin Kim,et al.  Ginsenoside Rg1 Promotes Glucose Uptake Through Activated AMPK Pathway in Insulin‐resistant Muscle Cells , 2012, Phytotherapy research : PTR.

[202]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[203]  J. Hodgson,et al.  Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice. , 2013, Journal of agricultural and food chemistry.

[204]  Yan Li,et al.  Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo. , 2011, Diabetes research and clinical practice.

[205]  S. Ignacimuthu,et al.  Antidiabetic effect of plumbagin isolated from Plumbago zeylanica L. root and its effect on GLUT4 translocation in streptozotocin-induced diabetic rats. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[206]  C. K. Zimpel,et al.  Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats. , 2013, Research in veterinary science.

[207]  N. Al-Dhabi,et al.  Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway. , 2014, European journal of pharmacology.

[208]  Jin-Taek Hwang,et al.  Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice , 2012, Molecular and Cellular Endocrinology.

[209]  S. Ryu,et al.  Emodin Regulates Glucose Utilization by Activating AMP-activated Protein Kinase* , 2013, The Journal of Biological Chemistry.

[210]  F. Thong,et al.  The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes , 2015, Pharmacognosy magazine.

[211]  S. Chirumbolo Flavonoids in coronary heart disease. , 2015, Thrombosis research.

[212]  Chia-Yu Hsu,et al.  Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation. , 2014, Molecular nutrition & food research.

[213]  P. Gu,et al.  Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice , 2012, Journal of Endocrinological Investigation.

[214]  P. Kalaiarasi,et al.  Antihyperglycemic effect of 18 beta-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats. , 2009, European journal of pharmacology.

[215]  Mi-Kyung Lee,et al.  Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice. , 2014, Indian journal of experimental biology.

[216]  Yue Liu,et al.  Roles and mechanisms of ginsenoside in cardiovascular diseases: progress and perspectives , 2016, Science China Life Sciences.

[217]  Dong Geon Kim,et al.  Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. , 2012, Metabolism: clinical and experimental.

[218]  Linhua Zhao,et al.  Administration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes Mellitus , 2016, Journal of diabetes research.

[219]  Javed Ali,et al.  Rutin: therapeutic potential and recent advances in drug delivery , 2013, Expert opinion on investigational drugs.

[220]  P. Ponmurugan,et al.  Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats. , 2015, Journal of the science of food and agriculture.

[221]  M. Noh,et al.  Bavachin from Psoralea corylifolia Improves Insulin-Dependent Glucose Uptake through Insulin Signaling and AMPK Activation in 3T3-L1 Adipocytes , 2016, International journal of molecular sciences.

[222]  R. Harini,et al.  Antihyperglycemic effect of protocatechuic acid on streptozotocin-diabetic rats , 2010, Journal of basic and clinical physiology and pharmacology.

[223]  Y. Yoshimura,et al.  Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-A(y) mice. , 2013, Biochemical and biophysical research communications.

[224]  H. Ni,et al.  The study of ginsenoside on PPARγ expression of mononuclear macrophage in type 2 diabetes , 2010, Molecular Biology Reports.

[225]  S. Ojha,et al.  Up-regulation of PPARγ, heat shock protein-27 and -72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes , 2011, British Journal of Nutrition.

[226]  S. Srinivasan,et al.  Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats , 2017, Pharmaceutical biology.

[227]  Y. Kuo,et al.  Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation. , 2014, Journal of agricultural and food chemistry.

[228]  K. Maiese New Insights for Oxidative Stress and Diabetes Mellitus , 2015, Oxidative medicine and cellular longevity.

[229]  F. Amati,et al.  Revisiting the diacylglycerol‐induced insulin resistance hypothesis , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[230]  F. Lu,et al.  Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. , 2004, Acta pharmacologica Sinica.

[231]  D. Indumathi,et al.  Antidiabetic and antihyperlipidemic activity of p-coumaric acid in diabetic rats, role of pancreatic GLUT 2: In vivo approach. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[232]  J. Yanovski,et al.  Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation. , 2016, Medical hypotheses.

[233]  Jie Hao,et al.  Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway , 2016, Molecular and Cellular Endocrinology.

[234]  Mei Yang,et al.  Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction , 2013, Experimental Gerontology.

[235]  M. Lane,et al.  Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. , 2009, American journal of physiology. Endocrinology and metabolism.

[236]  Po-Shiuan Hsieh,et al.  Activation of Estrogen Receptor Is Crucial for Resveratrol-Stimulating Muscular Glucose Uptake via Both Insulin-Dependent and -Independent Pathways , 2008, Diabetes.

[237]  Wenfeng Zhang,et al.  Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease. , 2014, Annals of hepatology.

[238]  Jen-kun Lin,et al.  Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. , 2008, Molecular nutrition & food research.

[239]  K. Zhou,et al.  Baicalein Protects against Type 2 Diabetes via Promoting Islet β-Cell Function in Obese Diabetic Mice , 2014, International journal of endocrinology.

[240]  Wei Zhu,et al.  Effects of resveratrol on the amelioration of insulin resistance in KKAy mice. , 2012, Canadian journal of physiology and pharmacology.

[241]  Dong Geon Kim,et al.  Effects of resveratrol on the insulin signaling pathway of obese mice , 2014, Journal of veterinary science.

[242]  Hongmei Jiang,et al.  Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes , 2016, Mediators of inflammation.

[243]  J. A. Scarlett,et al.  Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. , 1982, The American journal of physiology.

[244]  Myung-Sook Choi,et al.  Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. , 2006, The international journal of biochemistry & cell biology.

[245]  T. Osawa,et al.  Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. , 2004, Biochemical and biophysical research communications.